Advertisement

Inhalationsanästhetika: Wann von Vorteil, wann von Nachteil?

  • P. Conzen
Chapter
  • 11 Downloads
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 222)

Zusammenfassung

Die Frage nach den Vor- und Nachteilen der Inhalationsanästhetika muß sich im Zusammenhang mit der Narkose von koronarkranken Patienten insbesondere mit der Situation des ischämiebedrohten Myokards auseinandersetzen. Im folgenden sollen deshalb die wesentlichen Wirkungen der gegenwärtig klinisch eingesetzten Inhalationsanästhetika kurz dargestellt und in ihrer Wertigkeit für das ischämiebedrohte Myokard diskutiert werden. Eine allzu detaillierte Zusammenfassung würde den Rahmen dieser Arbeit sprengen. Eine ausführliche Darstellung enthält jedoch ein kürzlich publizierter Übersichtsartikel von Hobbhahn et al. [1 1].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bastard OG, Carter JG, Moyers JR, Bross BA (1982) Isoflurane vs. halothane in ischemic heart disease. Anesth Analg 61: 170–171Google Scholar
  2. 2.
    Buffington CW, Davis KB, Gillispie S, Pettinger M (1988) The prevalence of steal-prone coronary anatomy in patients with coronary artery disease: An analysis of the coronary artery surgery study registry. Anesthesiology 69: 721–727PubMedCrossRefGoogle Scholar
  3. 3.
    Cahalan MK, Lurz FW, Eger EI II, Schwartz LA, Beaupre PN, Smith JS (1987) Narcotics decrease heart rate during inhalational anesthesia. Anesth Analg 66: 166–170PubMedCrossRefGoogle Scholar
  4. 4.
    Coetzee A, Fourie P, Badenhorst E (1987) Effect of halothane, enflurane and isoflurane on the end-systolic pressure-length relationship. Can J Anaesth 34: 351–355PubMedCrossRefGoogle Scholar
  5. 5.
    Conzen PF, Hobbhahn J, Goetz AE, Habazettl H, Granetzny T, Peter K, Brendel W (1989) Myocardial contractility, blood flow, and oxygen consumption in healthy dogs during anesthesia with isoflurane or enflurane. J Cardiothorac Anesth 3: 70–77PubMedCrossRefGoogle Scholar
  6. 6.
    Conzen PF, Hobbhahn J, Goetz AE, Gonschior P, Seidl G, Peter K, Brendel W (1989) Regional blood flow and tissue oxygen pressures of the collateral-dependent Anesthesiology 70: 442–452Google Scholar
  7. 7.
    Eger EI (1984) Isoflurane (forane). A compendium and reference. Madison WJ Ohio Med Products 1: 110Google Scholar
  8. 8.
    Hantler CB, Wilton FN, Learned DM, Hill AE, Knight PR (1987) Impaired moyocardial conduction in patients with diltiazem therapy during enflurane anesthesia. Anesthesiology 67: 94–96PubMedCrossRefGoogle Scholar
  9. 9.
    Hess W, Arnold B, Schulte-Sasse U, Tarnow J (1983) Comparison of isoflurane and halothane when used to control intraoperatrive hypertension in patients undergoing coronary artery bypass sugery. Anesth Analg 62: 15–20PubMedGoogle Scholar
  10. 10.
    Hirshman CA, Edelstein G, Peetz S, Wayne S, Downes H (1982) Mechanism of action of inhalational anesthesia on airways. Anesthesiology 56: 107–111PubMedCrossRefGoogle Scholar
  11. 11.
    Hobbhahn J, Conzen P, Forst H, Peter K (1989) Einfluß von Inhalationsanästhetika auf das Myokard. Anaesthesist 38:S 561–596Google Scholar
  12. 12.
    Hobbhahn J, Conzen PFM, Goetz A, Seidl G, Gonschior P, Brendel W, Peter K (1989) Myocardial surface P02–an indicator of myocardial tissue oxygenation? Cardiovasc Res 23: 529–540PubMedCrossRefGoogle Scholar
  13. 13.
    Hoka S, Bosnjak ZJ, Kampine JP (1987) Halothane inhibits calcium accumulation following myocardial ischemia and calcium paradox in guinea pig hearts. Anesthesiology 67: 541–456CrossRefGoogle Scholar
  14. 14.
    Johnstone RR, Eger EL II, Wilson C (1976) A comparative interaction of epinephrine with enflurane, isoflurane and halothane in man. Anesth Analg 55: 709–713Google Scholar
  15. 15.
    Kemmotsu O, Hashimoto Y, Shimosato S (1973) Inotropic effects of isoflurane on mechanics of contraction in isolated cat papillary muscles from normal and failing hearts. Anesthesiology 39: 470–477PubMedCrossRefGoogle Scholar
  16. 16.
    Kotrly KJ, Ebert TJ, Vucins E, Igler EO, Barney JA, Kampine JP (1984) Baroreceptor reflex control of heart rate during isoflurane anesthesia in humans. Anesthesisology 60: 173–179CrossRefGoogle Scholar
  17. 17.
    Kroll DA, Knight PR (1984) Antifibrillatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias. Anesthesiology 61: 657–672PubMedCrossRefGoogle Scholar
  18. 18.
    Mallow JE, White RD, Cucchiara RF, Tarhan S (1976) Hemodynamic effects of isoflurane and halothane in patients with coronary artery disease. Anesth Analg 55: 135–138PubMedCrossRefGoogle Scholar
  19. 19.
    Martin E, Forst H, Hobbhahn J, Schmitz E, Peter K (1987) Einfluß volatiler Anästhetika ( Halothan, Isofluran) auf die zentrale and periphere Hämodynamik bei Clamping and Declamping der Aorta abdominalis. Anästhesist 34:3Google Scholar
  20. 20.
    Moffitt EA, Barker RA, Glenn JJ et al. Myocardial metabolism and hemodynamic responses with isoflurane anesthesia for coronary arftery surgery. Anesth Analg 65: 53–61Google Scholar
  21. 21.
    Reiz S, Balfors E, Sorensen MB, Ariola S, Friedmann A, Truedsson H (1983) Isoflurane–a powerful coronary vaodilator in patients with coronary artery disease. Anesthesiology 59: 91–97PubMedCrossRefGoogle Scholar
  22. 22.
    Roizen MF, Hamilton WK, Sohn YJ (1981) Treatment of stress-induced increases in pulmonary capillary wedge pressure using volatile anesthetics. Anesthesiology 55: 446–450PubMedCrossRefGoogle Scholar
  23. 23.
    Sahlman L, Milocco I, Appelgren L, William-Olsson G, Ricksten S-E (1989) Control of intraoperative hypertension with isoflurane in patients with coronary artery disease. Anesth Analg 68: 105–111PubMedCrossRefGoogle Scholar
  24. 24.
    Slogoff S, Keats AS (1989) Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 70: 179–188PubMedCrossRefGoogle Scholar
  25. 25.
    Tarnow J, Bruckner JB, Eberlein HJ, Hess W, Patschke D (1976) Haemodynamics and myocardial oxygen consumption during isoflurane (forane) anesthesia in geriatric patients. Br J Anaesth 48: 669–675PubMedCrossRefGoogle Scholar
  26. 26.
    Tarnow J, Markschies-Hornung A, Schulte-Sasse U (1986) Isoflurane improves the tolerance to pacing-induced myocardial ischemia. Anesthesiology 64: 146–156CrossRefGoogle Scholar
  27. 27.
    Tuman KJ, McCarthy RJ, Spiess BD, DeValle M, Dabir R, Ivankovich AD (1989) Does coice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 70: 189–198PubMedCrossRefGoogle Scholar
  28. 28.
    Warltier DC, Al-Wathiqui MH, Kampine JP, Schmeling WT (1988) Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 69: 552–556PubMedCrossRefGoogle Scholar
  29. 29.
    Witzeling TM, Sill JC, Hughes JM, Blaise GA, Nugent M, Rorie DK (1990) Isofluraneand halothane attenuate coronary artery constriction evoked by serotonin in isolated porcine vessels and in intact pigs. Anesthesiology 73: 100–108PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • P. Conzen

There are no affiliations available

Personalised recommendations